DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Karyopharm Therapeutics Inc. (KPTI)
« Back to company indexKPTI Chatter Timeline
Stock Ticker for KPTI
Most Active Tweeters for KPTI
| User | Tweets |
|---|---|
| @Gambiste1 | 87 |
| @thomasmcdanie20 | 19 |
| @1MinuteStock | 11 |
| @Biotech2050 | 10 |
| @TickerReport | 10 |
Recent Tweets for KPTI
 |
@traderefinery $KPTI ..... I missed this trade ^^ https://t.co/C9YPBPTBZB July 15th 2019, 10:07pm |
 |
@B1GCAPS $KPTI the hardest part is done. Now its time to get indications over time. This will double and triple as each indi… https://t.co/1jbUjQidr4 July 15th 2019, 9:07pm |
 |
@Jcaptrading $KPTI another set up is gaps up or big moves up. Wait for retracement n draw fibs from the beginning of the move.… https://t.co/WjuAPW5HRQ July 15th 2019, 7:07pm |
 |
@PennyStocksMomo MOMOs ? ClayTrader: * * $KPTI Video Chart 07-15-2019 * * https://t.co/FmhjpDaenU via ? https://t.co/7Ao8RTbZ6I July 15th 2019, 6:07pm |
|
@PennyStocksMomo BBs StockHaven ? ClayTrader: * * $KPTI Video Chart 07-15-2019 * * https://t.co/BdA576E7pO via ? https://t.co/7Ao8RTbZ6I July 15th 2019, 5:07pm |
 |
@ClayTrader25 VIDEO - $KPTI Stock Technical Analysis - 07-15-2019 - watch here: https://t.co/pHkeOVKJL8 #stock #stocks #stocktrading July 15th 2019, 5:07pm |
 |
@SoupLyfe563 Our swing on $KPTI starting to shape up here from $8.06 entry on July 10th. Not the best entry, but we green July 15th 2019, 4:07pm |
 |
@TopStockAlerts1 $KPTI Ran all day. Setting up for continuation. On top of my list fotomorrow. July 15th 2019, 4:07pm |
 |
@InsiderAlertsIA $KPTI: New Insider Filing on EVP, Chief Medical Officer JATIN SHAH: https://t.co/6rdLmP5cSv July 15th 2019, 4:07pm |
 |
@confcalltran EVP of Karyopharm Therapeutics Inc was just granted 35,350 options and restricted shares https://t.co/7ycTbFQRzB $KPTI July 15th 2019, 4:07pm |
 |
@ConsumerFeed Zacks: Analysts Anticipate Karyopharm Therapeutics Inc $KPTI Will Post Earnings of -$0.97 Per Share https://t.co/1Lxm3PSA1W July 15th 2019, 3:07pm |
 |
@Greatstockpix $KPTI nice turn today. July 15th 2019, 3:07pm |
|
@B1GCAPS $KPTI train is starting to leave https://t.co/RQ4vSJ5FTp July 15th 2019, 3:07pm |
 |
@ACInvestorBlog $KPTI Old alert. Back over its EMA200 https://t.co/HWofac8XX3 July 15th 2019, 3:07pm |
 |
@Ezehtim $KPTI someone trying to shake folks out with stops. Big boys will take this to $10 this week July 15th 2019, 3:07pm |
 |
@bret_jensen $KPTI $XBI Good article on why multiple myeloma might just be the first of several indications Xpovio wins for Kary… https://t.co/c6vj6Cd9Q7 July 15th 2019, 1:07pm |
 |
@ilovestocks85 $KPTI expecting $12+ in the coming weeks July 15th 2019, 1:07pm |
 |
@BonanzaBiotech Nice break higher in $KPTI almost pulled the trigger this morning as it was defending the $7.80 level. Would have been a nice gainer. July 15th 2019, 12:07pm |
|
@ilovestocks85 $KPTI here we go July 15th 2019, 12:07pm |
 |
@thomasmcdanie20 $KPTI nice continuation from Friday lows. Should break above 200 sma and hold. July 15th 2019, 12:07pm |
 |
@StocksThatGo $KPTI R/G move here decent looking multi day multi week swing from red green level of 8.05-8.10 range. July 15th 2019, 11:07am |
|
@Ezehtim $KPTI future of selenixor is beyond myeloma. Approval was likely due to the fda seeing promise in other diseases like lymphoma and glio July 15th 2019, 10:07am |
 |
@anotones Looks about ready to break to the up side. $kpti July 15th 2019, 10:07am |
 |
@moshakes_911 $KPTI on watch for reversal! July 15th 2019, 9:07am |
 |
@OlympiaReport ValuEngine Downgrades Karyopharm Therapeutics $KPTI to Hold https://t.co/kEfbWnWl0z July 15th 2019, 7:07am |
 |
@dispatchtribune ValuEngine Downgrades Karyopharm Therapeutics $KPTI to Hold https://t.co/guJCMaOrwv July 15th 2019, 7:07am |
 |
@registrarjourn ValuEngine Downgrades Karyopharm Therapeutics $KPTI to Hold https://t.co/sXSGVDWZjq July 15th 2019, 7:07am |
 |
@EnterpriseLeade ValuEngine Downgrades Karyopharm Therapeutics $KPTI to Hold https://t.co/oVfKKAkG7q July 15th 2019, 7:07am |
|
@dispatchtribune Karyopharm Therapeutics $KPTI Stock Rating Lowered by Zacks Investment Research https://t.co/au5Cys6hov July 15th 2019, 1:07am |
 |
@TickerReport Karyopharm Therapeutics $KPTI Downgraded by Zacks Investment Research to Hold https://t.co/8eNCM12sCI July 15th 2019, 1:07am |
|
@Jcaptrading RT @semodough: $KPTI Appears FDA evaluated much patient commentary, patients in need &patients that had great success on their drug with li… July 14th 2019, 8:07pm |
 |
@semodough $KPTI Appears FDA evaluated much patient commentary, patients in need &patients that had great success on their dru… https://t.co/SzWY1RwRhP July 14th 2019, 12:07pm |
|
@EnterpriseLeade Karyopharm Therapeutics $KPTI Raised to Buy at Zacks Investment Research https://t.co/NhYQPvYIad July 14th 2019, 6:07am |
|
@registrarjourn Karyopharm Therapeutics $KPTI Raised to Buy at Zacks Investment Research https://t.co/7DHUsB80Sc July 14th 2019, 6:07am |
 |
@stocknewstimes Karyopharm Therapeutics $KPTI Raised to Buy at Zacks Investment Research https://t.co/gO0fVjZS8A July 14th 2019, 6:07am |
 |
@WeekHerald Karyopharm Therapeutics $KPTI Raised to Buy at Zacks Investment Research https://t.co/UqsIYkFzoQ July 14th 2019, 6:07am |
 |
@Biotech2050 These are the experiences of other patients on $KPTI selinexor trials submitted to the FDA https://t.co/0IgfInh1FW July 14th 2019, 6:07am |
|
@Biotech2050 Real life experiences of a patient on selinexor trial https://t.co/5lgTTpr6pu $KPTI #mmsm #myeloma July 14th 2019, 6:07am |
|
@Biotech2050 @diberri @thomasmcdanie20 #3 And if you are trying to connect the dots between $CELG $KPTI and selinexor this is th… https://t.co/zGNpAMcdvl July 14th 2019, 3:07am |
|
@Biotech2050 Antengene (and indirectly $CELG) have initiated 2 trials in 2019 using $KPTI selinexor giving Celgene full insider… https://t.co/9gJAaGYSzt July 14th 2019, 1:07am |
|
@Biotech2050 #selinexor $KPTI China partner 1. Antengene has filing plans in #rrmm and following indications with health authori… https://t.co/gH96epa5sN July 14th 2019, 12:07am |
|
@Biotech2050 Antengene's pipeline includes $KPTI #selinexor for Asian territory https://t.co/fzLHWqpN2N July 14th 2019, 12:07am |
 |
@GoGoBio RT @thomasmcdanie20: $KPTI JEFF KPTI ests ~6K pts based on the defined label; conservatively, that would imply $162M mkt oppty assuming the… July 13th 2019, 11:07pm |
 |
@BursatilBiotech Okay so I've found the perfect gif for $KPTI's approval Not saying the drug might be good for pts but why not relea… https://t.co/NRYCvxGr8A July 13th 2019, 1:07pm |
 |
@IRAMarketReport Karyopharm Therapeutics $KPTI Lifted to “Buy” at Zacks Investment Research https://t.co/04ev8X4rr6 #markets July 13th 2019, 9:07am |
 |
@chaffeybreeze Karyopharm Therapeutics $KPTI Lifted to “Buy” at Zacks Investment Research https://t.co/Ag3FKfKHRM #stocks July 13th 2019, 9:07am |
 |
@9parvin9 RT @ACInvestorBlog: $KPTI popping on volume July 13th 2019, 8:07am |
|
@ConsumerFeed Karyopharm Therapeutics $KPTI Lifted to “Buy” at Zacks Investment Research https://t.co/SBqIqpXrI6 July 13th 2019, 8:07am |
|
@TickerReport ValuEngine Downgrades Karyopharm Therapeutics $KPTI to Hold https://t.co/VnvDO2IqLO July 13th 2019, 4:07am |
|
@TickerReport B. Riley Weighs in on Karyopharm Therapeutics Inc’s Q2 2019 Earnings $KPTI https://t.co/VhE3UBSfY1 July 13th 2019, 1:07am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.